Empresa Acerus Pharmaceuticals Corporation
Acciones
ASPCF
CA00444G4051
Farmacéuticos
Resumen de negocios
Número de empleados: 14
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Edward Gudaitis
CEO | Chief Executive Officer | - | 01/05/18 |
Naveed Manzoor
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | - | 17/07/20 | |
Philippe Savard
LAW | General Counsel | - | 04/07/16 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Director/Board Member | 74 | - | |
Ian Ihnatowycz
CHM | Chairman | 71 | 09/09/13 |
Borys Chabursky
BRD | Director/Board Member | - | 20/12/15 |
Edward Gudaitis
CEO | Chief Executive Officer | - | 01/05/18 |
Stephen Gregory
BRD | Director/Board Member | - | 14/07/11 |
Geoff Cotton
BRD | Director/Board Member | - | 01/05/20 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 7 702 297 | 662 312 ( 8,599 %) | 0 | 8,599 % |
Información de la empresa
Acerus Pharmaceuticals Corp.
7025 Langer Drive Suite 205
L5N 0E8, Mississauga
+
http://www.aceruspharma.comVaria. 1 de ene. | Capi. | |
---|---|---|
+38,51 % | 727 mil M | |
+33,05 % | 599 mil M | |
-6,23 % | 354 mil M | |
+18,78 % | 328 mil M | |
+1,35 % | 277 mil M | |
+16,00 % | 243 mil M | |
+8,09 % | 205 mil M | |
-5,77 % | 203 mil M | |
+6,19 % | 164 mil M |